BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 17981146)

  • 1. Octapeptide repeat region of prion protein (PrP) is required at an early stage for production of abnormal prion protein in PrP-deficient neuronal cell line.
    Sakudo A; Wu G; Onodera T; Ikuta K
    Biochem Biophys Res Commun; 2008 Jan; 365(1):164-9. PubMed ID: 17981146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The number of octapeptide repeat affects the expression and conversion of prion protein.
    Hiraga C; Kobayashi A; Kitamoto T
    Biochem Biophys Res Commun; 2009 May; 382(4):715-9. PubMed ID: 19318088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The octarepeat region of the prion protein is conformationally altered in PrP(Sc).
    Yam AY; Gao CM; Wang X; Wu P; Peretz D
    PLoS One; 2010 Feb; 5(2):e9316. PubMed ID: 20195363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
    Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
    J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotoxic prion protein (PrP) fragment 106-126 requires the N-terminal half of the hydrophobic region of PrP in the PrP-deficient neuronal cell line.
    Sakudo A; Nakamura I; Lee DC; Saeki K; Ikuta K; Onodera T
    Protein Pept Lett; 2007; 14(1):1-6. PubMed ID: 17266643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion and doppel proteins bind to granule cells of the cerebellum.
    Legname G; Nelken P; Guan Z; Kanyo ZF; DeArmond SJ; Prusiner SB
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16285-90. PubMed ID: 12446843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential solubility of prions is associated in manifold phenotypes.
    Kuczius T; Karch H; Groschup MH
    Mol Cell Neurosci; 2009 Nov; 42(3):226-33. PubMed ID: 19607920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follicular dendritic cell of the knock-in mouse provides a new bioassay for human prions.
    Kitamoto T; Mohri S; Ironside JW; Miyoshi I; Tanaka T; Kitamoto N; Itohara S; Kasai N; Katsuki M; Higuchi J; Muramoto T; Shin RW
    Biochem Biophys Res Commun; 2002 Jun; 294(2):280-6. PubMed ID: 12051707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective re-routing of prion protein to proteasomes and alteration of its vesicular secretion prevent PrP(Sc) formation.
    Filesi I; Cardinale A; Mattei S; Biocca S
    J Neurochem; 2007 Jun; 101(6):1516-26. PubMed ID: 17542810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocatalytic self-propagation of misfolded prion protein.
    Bieschke J; Weber P; Sarafoff N; Beekes M; Giese A; Kretzschmar H
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12207-11. PubMed ID: 15297610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The scrapie prion protein is present in flotillin-1-positive vesicles in central- but not peripheral-derived neuronal cell lines.
    Pimpinelli F; Lehmann S; Maridonneau-Parini I
    Eur J Neurosci; 2005 Apr; 21(8):2063-72. PubMed ID: 15869502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
    Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
    Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histidines in the octapeptide repeat of PrPC react with PrPSc at an acidic pH.
    Cruite JT; Abalos GC; Bellon A; Solforosi L
    Biochemistry; 2011 Mar; 50(10):1618-23. PubMed ID: 21268659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prion protein and copper: a mysterious relationship].
    Rachidi W; Riondel J; McMahon HM; Favier A
    Pathol Biol (Paris); 2005 May; 53(4):244-50. PubMed ID: 15850959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine cultured cells counteract persistent prion infection by down-regulation of PrPc.
    Aguib Y; Gilch S; Krammer C; Ertmer A; Groschup MH; Schätzl HM
    Mol Cell Neurosci; 2008 May; 38(1):98-109. PubMed ID: 18387818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards cellular receptors for prions.
    Lee KS; Linden R; Prado MA; Brentani RR; Martins VR
    Rev Med Virol; 2003; 13(6):399-408. PubMed ID: 14625887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PrP cooperates with STI1 to regulate SOD activity in PrP-deficient neuronal cell line.
    Sakudo A; Lee DC; Li S; Nakamura T; Matsumoto Y; Saeki K; Itohara S; Ikuta K; Onodera T
    Biochem Biophys Res Commun; 2005 Mar; 328(1):14-9. PubMed ID: 15670743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A monoclonal antibody (1D12) defines novel distribution patterns of prion protein (PrP) as granules in nucleus.
    Hosokawa T; Tsuchiya K; Sato I; Takeyama N; Ueda S; Tagawa Y; Kimura KM; Nakamura I; Wu G; Sakudo A; Casalone C; Mazza M; Caramelli M; Takahashi H; Sata T; Sugiura K; Baj A; Toniolo A; Onodera T
    Biochem Biophys Res Commun; 2008 Feb; 366(3):657-63. PubMed ID: 18068119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominant-negative inhibition of prion replication in transgenic mice.
    Perrier V; Kaneko K; Safar J; Vergara J; Tremblay P; DeArmond SJ; Cohen FE; Prusiner SB; Wallace AC
    Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13079-84. PubMed ID: 12271119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.